215 related articles for article (PubMed ID: 11145227)
1. Pharmacokinetic-pharmacodynamic modelling of morphine transport across the blood-brain barrier as a cause of the antinociceptive effect delay in rats--a microdialysis study.
Bouw MR; Gårdmark M; Hammarlund-Udenaes M
Pharm Res; 2000 Oct; 17(10):1220-7. PubMed ID: 11145227
[TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier transport and brain distribution of morphine-6-glucuronide in relation to the antinociceptive effect in rats--pharmacokinetic/pharmacodynamic modelling.
Bouw MR; Xie R; Tunblad K; Hammarlund-Udenaes M
Br J Pharmacol; 2001 Dec; 134(8):1796-804. PubMed ID: 11739257
[TBL] [Abstract][Full Text] [Related]
3. Blood-brain barrier equilibration of codeine in rats studied with microdialysis.
Xie R; Hammarlund-Udenaes M
Pharm Res; 1998 Apr; 15(4):570-5. PubMed ID: 9587953
[TBL] [Abstract][Full Text] [Related]
4. Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat.
Letrent SP; Pollack GM; Brouwer KR; Brouwer KL
Drug Metab Dispos; 1999 Jul; 27(7):827-34. PubMed ID: 10383928
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetic modelling of non-linear brain distribution of morphine: influence of active saturable influx and P-glycoprotein mediated efflux.
Groenendaal D; Freijer J; de Mik D; Bouw MR; Danhof M; de Lange EC
Br J Pharmacol; 2007 Jul; 151(5):701-12. PubMed ID: 17471182
[TBL] [Abstract][Full Text] [Related]
6. Morphine blood-brain barrier transport is influenced by probenecid co-administration.
Tunblad K; Jonsson EN; Hammarlund-Udenaes M
Pharm Res; 2003 Apr; 20(4):618-23. PubMed ID: 12739770
[TBL] [Abstract][Full Text] [Related]
7. In vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics/pharmacodynamics.
Boström E; Simonsson US; Hammarlund-Udenaes M
Drug Metab Dispos; 2006 Sep; 34(9):1624-31. PubMed ID: 16763013
[TBL] [Abstract][Full Text] [Related]
8. Modelling of the blood-brain barrier transport of morphine-3-glucuronide studied using microdialysis in the rat: involvement of probenecid-sensitive transport.
Xie R; Bouw MR; Hammarlund-Udenaes M
Br J Pharmacol; 2000 Dec; 131(8):1784-92. PubMed ID: 11139459
[TBL] [Abstract][Full Text] [Related]
9. Blood-brain barrier transport of morphine in patients with severe brain trauma.
Ederoth P; Tunblad K; Bouw R; Lundberg CJ; Ungerstedt U; Nordström CH; Hammarlund-Udenaes M
Br J Clin Pharmacol; 2004 Apr; 57(4):427-35. PubMed ID: 15025740
[TBL] [Abstract][Full Text] [Related]
10. Influence of biophase distribution and P-glycoprotein interaction on pharmacokinetic-pharmacodynamic modelling of the effects of morphine on the EEG.
Groenendaal D; Freijer J; de Mik D; Bouw MR; Danhof M; de Lange EC
Br J Pharmacol; 2007 Jul; 151(5):713-20. PubMed ID: 17471181
[TBL] [Abstract][Full Text] [Related]
11. Oxymorphone active uptake at the blood-brain barrier and population modeling of its pharmacokinetic-pharmacodynamic relationship.
Sadiq MW; Boström E; Keizer R; Björkman S; Hammarlund-Udenaes M
J Pharm Sci; 2013 Sep; 102(9):3320-31. PubMed ID: 23463542
[TBL] [Abstract][Full Text] [Related]
12. Altered brain exposure of morphine in experimental meningitis studied with microdialysis.
Tunblad K; Ederoth P; Gärdenfors A; Hammarlund-Udenaes M; Nordström CH
Acta Anaesthesiol Scand; 2004 Mar; 48(3):294-301. PubMed ID: 14982561
[TBL] [Abstract][Full Text] [Related]
13. Blood-brain barrier transport helps to explain discrepancies in in vivo potency between oxycodone and morphine.
Boström E; Hammarlund-Udenaes M; Simonsson US
Anesthesiology; 2008 Mar; 108(3):495-505. PubMed ID: 18292687
[TBL] [Abstract][Full Text] [Related]
14. Increased blood-brain barrier permeability of morphine in a patient with severe brain lesions as determined by microdialysis.
Bouw R; Ederoth P; Lundberg J; Ungerstedt U; Nordström CH; Hammarlund-Udenaes M
Acta Anaesthesiol Scand; 2001 Mar; 45(3):390-2. PubMed ID: 11207479
[TBL] [Abstract][Full Text] [Related]
15. Sex-related differences in morphine's antinociceptive activity: relationship to serum and brain morphine concentrations.
Cicero TJ; Nock B; Meyer ER
J Pharmacol Exp Ther; 1997 Aug; 282(2):939-44. PubMed ID: 9262361
[TBL] [Abstract][Full Text] [Related]
16. Physiologically based pharmacokinetic/pharmacodynamic model for the prediction of morphine brain disposition and analgesia in adults and children.
Verscheijden LFM; Litjens CHC; Koenderink JB; Mathijssen RHJ; Verbeek MM; de Wildt SN; Russel FGM
PLoS Comput Biol; 2021 Mar; 17(3):e1008786. PubMed ID: 33661919
[TBL] [Abstract][Full Text] [Related]
17. The role of P-glycoprotein in blood-brain barrier transport of morphine: transcortical microdialysis studies in mdr1a (-/-) and mdr1a (+/+) mice.
Xie R; Hammarlund-Udenaes M; de Boer AG; de Lange EC
Br J Pharmacol; 1999 Oct; 128(3):563-8. PubMed ID: 10516633
[TBL] [Abstract][Full Text] [Related]
18. Improved blood-brain barrier distribution: effect of borneol on the brain pharmacokinetics of kaempferol in rats by in vivo microdialysis sampling.
Zhang Q; Wu D; Wu J; Ou Y; Mu C; Han B; Zhang Q
J Ethnopharmacol; 2015 Mar; 162():270-7. PubMed ID: 25582491
[TBL] [Abstract][Full Text] [Related]
19. Methodological aspects of the use of a calibrator in in vivo microdialysis-further development of the retrodialysis method.
Bouw MR; Hammarlund-Udenaes M
Pharm Res; 1998 Nov; 15(11):1673-9. PubMed ID: 9833986
[TBL] [Abstract][Full Text] [Related]
20. Morphine-3-glucuronide has a minor effect on morphine antinociception. Pharmacodynamic modeling.
Gardmark M; Karlsson MO; Jonsson F; Hammarlund-Udenaes M
J Pharm Sci; 1998 Jul; 87(7):813-20. PubMed ID: 9649348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
